Eloxx Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-9.062; its P/E ratio is -0.09; Eloxx Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -3.36M	$ -4.11M	$ -6.71M	$ -7.04M	$ -7.02M
EBITDA	$ -3.12M	$ -3.88M	$ -6.41M	$ -6.72M	$ -6.83M
Net Income Common Stockholders	$ -3.59M	$ -4.34M	$ -6.23M	$ -6.32M	$ -7.51M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.78M	$ 4.54M	$ 5.17M	$ 19.46M	$ 24.55M
Total Assets	$ 6.04M	$ 5.99M	$ 7.20M	$ 21.12M	$ 26.88M
Total Debt	$ 5.76M	$ 6.11M	$ 6.24M	$ 13.38M	$ 13.41M
Net Debt	$ 983.00K	$ 1.56M	$ 1.07M	$ -6.08M	$ -11.14M
Total Liabilities	$ 26.09M	$ 24.59M	$ 23.49M	$ 31.78M	$ 31.86M
Stockholders Equity	$ -20.05M	$ -18.64M	$ -16.29M	$ -10.66M	$ -4.98M
Cash Flow	-
Free Cash Flow	$ -3.22M	$ -2.05M	$ -6.80M	$ -5.66M	$ -6.99M
Operating Cash Flow	$ -3.45M	$ -2.07M	$ -6.81M	$ -5.66M	$ -6.95M
Investing Cash Flow	$ 233.00K	$ 14.00K	$ 11.00K	-	$ -48.00K
Financing Cash Flow	$ 3.67M	$ 1.43M	$ -7.50M	$ 312.00K	$ 1.50M

Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History

Income Statement >

Eloxx Pharmaceuticals Debt to Assets

Balance Sheet >

Eloxx Pharmaceuticals Cash Flow

Cash Flow >

Eloxx Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing